home / stock / dtc / dtc news

DTC News and Press, Solo Brands Inc. Class A

Stock Information
Company Name: Solo Brands Inc. Class A
Stock Symbol: DTC
Market: NYSE
Website: solostove.com
Menu
DTC DTC Quote DTC Short DTC News DTC Articles DTC Message Board
Get DTC Alerts

News, Short Squeeze, Breakout and More Instantly...
DTC - CHUBBIES UNVEILS TEAM USA CAPSULE SERIES: A MULTI-YEAR CELEBRATION OF AMERICA'S OLYMPIC LEGACY

CHUBBIES UNVEILS TEAM USA CAPSULE SERIES: A MULTI-YEAR CELEBRATION OF AMERICA'S OLYMPIC LEGACY PR Newswire The 2024 Three-Part Series Honors Past, Present, and Future Champions AUSTIN, Texas , July 12, 2024 /PRNewswire/ -- Chubbies , the weekend-c...
DTC - Defence Receives No Objection Letter from Health Canada for Phase I Trial of Its ACCUM-002 (AccuTOX) as an Anti-Cancer Molecule in Patients with Melanoma

Vancouver, British Columbia--(Newsfile Corp. - July 8, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that it...

DTC - Defence's AccuTOX Boosts and Synergizes with Immune Checkpoint Inhibitors

Vancouver, British Columbia--(Newsfile Corp. - June 28, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce that De...

DTC - Defence's ARM-X Anti-Cancer Vaccine Inhibits Growth of Pre-Established Ovarian Cancer Resulting in Complete Responses in Treated Animals

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce th...
DTC - Defence's Chief Scientific Officer Dr. Moutih Rafei Discusses the Accum Platform for Cancer Treatments on Money Talk Radio with Ellis Martin

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to share the interv...

DTC - Ellis Martin Report: Defence Therapeutics Inc. (DTCFF) Dr. Moutih Rafei-Developing Vaccines and Platform Technologies for the Treatment of Cancer

Malibu, CA, United States (ABN Newswire) - Join Ellis Martin and Money Talk Radio for a conversation with Dr. Moutih Rafei, Chief Science Officer of Defence Therapeutics Inc. (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF). Defence Therapeutics is a publicly traded biotechnology company working on engin...

DTC - Solo Brands: Growth Turnaround Potential With Decent Risk-Reward

2024-06-11 23:20:47 ET Summary Solo Brands focuses on DTC business for outdoor and lifestyle products in the US. Stock performance has been disappointing, currently trading at $1.9 per share. It recently faced underperformance in marketing. The management has taken active step...
DTC - Defence to Participate in 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce its pa...

DTC - Defence's AccuTOX Published in the Prestigious Journal of Translational Medicine Its Peer Study with Preclinical Data on AccuTOX as an Anti-Cancer Molecule

Vancouver, British Columbia--(Newsfile Corp. - June 6, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce the p...

DTC - Defence Therapeutics Strengthens and Expands Global Patent Protection on Key Technologies

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the...
Next 10